EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Norwegian Randomised Trial of Laparoscopic versus Open Aortobifemoral Bypass: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST)

Syed S H Kazmi, Mehdi Sahba, Erik Mulder Pettersen, Anne H Krog, Morten W Fagerland, Jon Otto Sundhagen

European Journal of Vascular and Endovascular Surgery · 2025

DOI: 10.1016/j.ejvs.2025.09.046 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2025. Verfasst von Syed S H Kazmi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo…. Hauptthemen laut MEDLINE: Laparoscopy, Femoral Artery, Iliac Artery, Arterial Occlusive Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oslo universitetssykehus HF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to compare post-operative complications after laparoscopic and open aortobifemoral bypass (ABFB) for aorto-iliac occlusive disease (AIOD). METHODS: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST) is a multicentre, non-blinded, parallel group, randomised controlled superiority trial. The trial was funded by Oslo University Hospital and conducted at three Norwegian public hospitals between March 2013 and November 2022. In this randomised study, 126 patients with TransAtlantic InterSociety Consensus II (TASC II) type D lesions, with debilitating lifestyle limiting intermittent claudication or chronic limb threatening ischaemia, clinically classified as Fontaine IIb or worse, were randomised in a 1:1 ratio to either laparoscopic ABFB (n = 63) or open ABFB (n = 63) (ClinicalTrials.gov ID NCT01793662). The primary outcome was post-operative complications, including systemic, vascular, and local complications, during a follow up of 2.9 years. The primary analysis was conducted on an intention to treat basis, with an additional supporting analysis performed per protocol. RESULTS: Allocated surgery was performed in 62 (98%) and 60 (95%) individuals in the laparoscopic and open ABFB groups, respectively. Post-operative complications occurred in 21/62 patients (34%) in the laparoscopic group and 44/60 patients (73%) in the open ABFB group (difference -40 percentage points, 95% confidence interval -54 - -22; p < .001), during a mean follow up of 3.6 ± 2.5 years. The 30 day mortality rate was 2% (1/62) and 2% (1/60) for laparoscopic and open ABFB, respectively. Limb based primary patency, primary assisted patency, and secondary patency rates at one year were 98%, 98%, and 98% for laparoscopic ABFB and 95%, 96%, and 96% for open ABFB, respectively. At two years the rates were 98%, 98%, and 98% for laparoscopic ABFB and 94%, 95%, and 95% for open ABFB. CONCLUSION: Patients with AIOD, TASC II type D lesions have significantly fewer post-operative complications after laparoscopic than open ABFB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LaparoscopyFemoral ArteryIliac ArteryArterial Occlusive DiseasesBlood Vessel Prosthesis ImplantationAortic DiseasesHumansFemaleMaleNorwayAgedMiddle AgedPostoperative ComplicationsTreatment OutcomeVascular Patency

Stichwörter der Autor:innen

Aorto-iliac occlusive diseaseAortobifemoral bypassIntermittent claudicationLaparoscopy

Autor:innen und Institutionen

  • Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: sshkazmi@gmail.com.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Vascular Surgery, Østfold Central Hospital, Kalnes, Norway.
  • Department of Vascular Surgery, Sørlandet Hospital, Kristiansand, Norway.
  • Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.
  • Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.

Förderung

  • Oslo universitetssykehus HF

Zitieren

APA

Kazmi, S. S. H., Sahba, M., Pettersen, E. M., Krog, A. H., Fagerland, M. W., & Sundhagen, J. O. (2025). Norwegian Randomised Trial of Laparoscopic versus Open Aortobifemoral Bypass: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST). European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.09.046

Vancouver

Kazmi SSH, Sahba M, Pettersen EM, Krog AH, Fagerland MW, Sundhagen JO. Norwegian Randomised Trial of Laparoscopic versus Open Aortobifemoral Bypass: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST). European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2025.09.046

BibTeX
@article{Kazmi2025,
  author = {Kazmi, Syed S H and Sahba, Mehdi and Pettersen, Erik Mulder and Krog, Anne H and Fagerland, Morten W and Sundhagen, Jon Otto},
  title = {Norwegian Randomised Trial of Laparoscopic versus Open Aortobifemoral Bypass: The Norwegian Laparoscopic Aortic Surgery Trial (NLAST)},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2025},
  doi = {10.1016/j.ejvs.2025.09.046}
}
Kostenlos starten →